A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application

Villeneuve, Laurent; Thivolet, Charles; Bakrin, Naoual; Mohamed, Faheez; Isaac, Sylvie; Valette, Pierre-Jean; Gléhen, Olivier; Rousset, Pascal; Abba, J.; Abboud, Karine; Arvieux, C.; Balagué, Gisèle; Barrau, Vincent; Rejeb, Houda Ben; Béréder, Jean-Marc; Bibeau, Frédéric; Bouzard, D.; Brigand, Cécile; Carrère, Sébastien; Carretier, Michel; Chaisemartin, Cécile de; Chassang, Madleen; Chevallier, A; Courvoisier, Thomas; Dartigues, Peggy; Delroeux, Delphine; Désolneux, G.; Dohan, Anthony; Dromain, Clarisse; Dumont, Frédéric; Durand-Fontanier, Sylvaine; Élias, Dominique; Eveno, Clarisse; Évrard, Serge; Fay, Oscar; Ferron, Gwénaël; Geffroy, D.; Gilly, François-Noël; Fontaine, Julien; Goasguen, N.; Ghouti, Laurent; Goèré, Diane; Guilloit, Jean Marc; Guyon, Frédéric; Heyd, Bruno; Kaci, Rachid; Karoui, Mehdi; Kianmanesh, Réza; Labbé, Catherine; Lacroix, Joëlle; Lang-Avérous, Gerlinde; Laverrière, Marie‐Hélène; Lefèvre, Jérémie H.; Lelong, Bernard; Leroux, Agnès; Dico, Réa Lo; Loi, Valeria; Lorimier, G.; Marchal, Frédéric; Mariani, A.; Mariani, Pascale; Mariette, C.; Méeus, Pierre; Mery-Lamarche, Eliane; Messager, Mathieu; Msika, Simon; Nadeau, C.; Ortega‐Deballon, Pablo; Passot, Guillaume; Pétorin, C.; Peyrat, Patrice; Pezet, Denis; Piessen, Guillaume; Pirrò, N.; Pocard, Marc; Poizat, Flora; Porcheron, J.; Pourcher, Guillaume; Quénet, François; Rat, Patrick; Régimbeau, Jean‐Marc; Rousselot, Pierre; Sabbagh, Charles; Svrcek, Magali; Tétreau, Raphaël; Thibaudeau, Emilie; Tuech, J.‐J.; Valmary‐Degano, Séverine; Vaudoyer, Delphine; Velasco, Stéphane; Verriele-Beurrier, Véronique; Wernert, Romuald; Zinzindohoué, Franck

doi:10.1016/j.ejso.2016.03.015

Cited by 50 publications

(18 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Then analyses are only conducted on available biospecimens for which patients have given their local written consent. The RENA-RAD Working Group has been formed recently with expert radiologists in peritoneal carcinomatosis imaging [ 56 ]. They share experiences and develop common tools in order to standardize radiological assessment of patients who are suitable for CRS with HIPEC.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry

Villeneuve¹,

Passot²,

Gléhen³

et al. 2017

Orphanet J Rare Dis

Self Cite

View full text Add to dashboard Cite

BackgroundRare peritoneal cancers represent complex clinical situations requiring a specific and multidisciplinary management. Because of their rarity, lack of awareness and knowledge often leads to diagnostic delays and misdiagnosis. And patients are not systematically referred to expert centers as they should be. Clinicians and researchers also face unique challenges with these rare cancers, because it is hard to conduct adequately powered, controlled trials in such small patient population. This is how an observational patient registry constitutes a key instrument for the development of epidemiological and clinical research in the field of these rare cancers. It is the appropriate tool to pool scarce data for epidemiological research and to assess the impact of diagnostic and therapeutic strategies. We aimed to provide the outlines and the framework of the RENAPE observational registry and share our experience in the establishment of a national patient registry.ResultsThe RENAPE observational registry has been launched in 2010 thanks to institutional supports. It concerns only patients with a histological diagnosis confirming a peritoneal surface malignancy. A web secured clinical database has been implemented based on data management procedures according to the principles of international recommendations and regulatory statements. A virtual tumor bank is linked in order to the conduct translational studies. Specialized working groups have been established to continuously upgrade and evolve the common clinical and histological data elements following the last classifications and clinical practices. They contribute also to standardize clinical assessment and homogenize practices.ConclusionsThe RENAPE Registry may improve awareness and understanding of the rare peritoneal tumors into the incidence, prevalence, recurrence, survival and mortality rates, as well as treatment practices thereby enabling therapeutic intervention to be evaluated and ultimately optimized.Trial registrationClinicalTrials.gov Identifier: NCT02834169

show abstract

Section: Resultsmentioning

confidence: 99%

“…Specialists use transversal tools for quantitative and qualitative assessment of patients who are suitable for surgical treatment. The PROMISE® internet application has been developed to allow for a standardized assessment of the peritoneal disease extent intended of multidisciplinary teams and centers that treat patients with RPM [ 56 ].…”

Section: Resultsmentioning

confidence: 99%

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry

Villeneuve¹,

Passot²,

Gléhen³

et al. 2017

Orphanet J Rare Dis

Self Cite

View full text Add to dashboard Cite

show abstract

“…Different surgical scores (Fagotti score, Modified Fagotti score, PCI, Eisenkop scores and the surgical complexity score of Aletti; Brun, Rouzier, Uzan, & Daraï, 2008; Fagotti et al., 2006; Sugarbaker & Jablonski, 1995) and radiological tools (Suidan model) (Suidan et al., 2017) have been proposed to homogenise the initial management of OC disease, but the debate on which tool should be used is still opened. Recently, an internet tool named PROMISE (PeRitOneal MalIgnancy Stage Evaluation), which allows to produce simple, quick but precise and standardised pre‐, intra‐ and post‐operative reports of the extent of peritoneal metastases, and to determine PCI correlations among surgical, radiological and pathological findings, is available and could be used (Villeneuve et al., 2016). However, a standardisation to assess the resectability in the AOC patients is needed because a method to properly identify the patients who could benefit of a first surgical treatment is not clearly defined yet.…”

Section: Discussionmentioning

confidence: 99%

Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first‐line setting. Exhaustive analysis from the Rhone‐Alpes region

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The radiological PCI was evaluated using dedicated software developed at this institution and now available online; this provides a standardized collection form for evaluation of PCI (PROMISE ® ; RENAPE – BIG RENAPE, Centre Hospitalier Lyon Sud, Lyon, France). Two experienced radiologists worked independently.…”

Section: Methodsmentioning

confidence: 99%

Evaluation of the peritoneal carcinomatosis index with CT and MRI

Dohan

Hoeffel

Soyer

et al. 2017

British Journal of Surgery

101

View full text Add to dashboard Cite

show abstract

A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application

Cited by 50 publications

References 10 publications

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry

Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first‐line setting. Exhaustive analysis from the Rhone‐Alpes region

Evaluation of the peritoneal carcinomatosis index with CT and MRI

Contact Info

Product

Resources

About